Sepsis Newborn
12
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (12)
A Multi-center Quasi-experimental Study in Northern Italy to Evaluate the Impact of Sepsis Bundle in Obstetric Settings: the SOS Study
Single Vs Multi-strain Probiotics for Preterm Neonates
Late-onset Sepsis and Development
Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding?
The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis
Probiotic Supplementation in Extremely Preterm Infants in Scandinavia
Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease
Monitoring of Systemic or Organ Perfusion for Preterm Infants
Immune Dysfunction in Newborn Sepsis
Glove-based Care in the NICU to Prevent Late Onset Sepsis
The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis